Literature DB >> 23849788

Host cell tropism mediated by Australian bat lyssavirus envelope glycoproteins.

Dawn L Weir1, Ina L Smith, Katharine N Bossart, Lin-Fa Wang, Christopher C Broder.   

Abstract

Australian bat lyssavirus (ABLV) is a rhabdovirus of the lyssavirus genus capable of causing fatal rabies-like encephalitis in humans. There are two variants of ABLV, one circulating in pteropid fruit bats and another in insectivorous bats. Three fatal human cases of ABLV infection have been reported with the third case in 2013. Importantly, two equine cases also arose in 2013; the first occurrence of ABLV in a species other than bats or humans. We examined the host cell entry of ABLV, characterizing its tropism and exploring its cross-species transmission potential using maxGFP-encoding recombinant vesicular stomatitis viruses that express ABLV G glycoproteins. Results indicate that the ABLV receptor(s) is conserved but not ubiquitous among mammalian cell lines and that the two ABLV variants can utilize alternate receptors for entry. Proposed rabies virus receptors were not sufficient to permit ABLV entry into resistant cells, suggesting that ABLV utilizes an unknown alternative receptor(s). Published by Elsevier Inc.

Entities:  

Keywords:  Australian bat lyssavirus; Emerging; Encephalitis; Envelope glycoprotein; Rabies virus; Receptor; Rhabdovirus; Tropism; Viral entry; Zoonosis

Mesh:

Substances:

Year:  2013        PMID: 23849788      PMCID: PMC6183051          DOI: 10.1016/j.virol.2013.06.016

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  38 in total

1.  Defining the risk of human exposure to Australian bat lyssavirus through potential non-bat animal infection.

Authors:  Bradley J McCall; Hume E Field; Greg A Smith; Greg J Storie; Bruce J Harrower
Journal:  Commun Dis Intell Q Rep       Date:  2005

2.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

3.  Interaction of lyssaviruses with the low-affinity nerve-growth factor receptor p75NTR.

Authors:  Christine Tuffereau; Emmanuel Desmézières; Jacqueline Bénéjean; Corinne Jallet; Anne Flamand; Noël Tordo; Pierre Perrin
Journal:  J Gen Virol       Date:  2001-12       Impact factor: 3.891

4.  Amino acid sequence similarity between rabies virus glycoprotein and snake venom curaremimetic neurotoxins.

Authors:  T L Lentz; P T Wilson; E Hawrot; D W Speicher
Journal:  Science       Date:  1984-11-16       Impact factor: 47.728

Review 5.  Sulfated polysaccharides extracted from sea algae as potential antiviral drugs.

Authors:  M Witvrouw; E De Clercq
Journal:  Gen Pharmacol       Date:  1997-10

6.  A single amino acid substitution in the transmembrane envelope glycoprotein of feline immunodeficiency virus alters cellular tropism.

Authors:  T W Vahlenkamp; E J Verschoor; N N Schuurman; A L van Vliet; M C Horzinek; H F Egberink; A de Ronde
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

7.  Encephalitis caused by a Lyssavirus in fruit bats in Australia.

Authors:  G C Fraser; P T Hooper; R A Lunt; A R Gould; L J Gleeson; A D Hyatt; G M Russell; J A Kattenbelt
Journal:  Emerg Infect Dis       Date:  1996 Oct-Dec       Impact factor: 6.883

8.  Is the acetylcholine receptor a rabies virus receptor?

Authors:  T L Lentz; T G Burrage; A L Smith; J Crick; G H Tignor
Journal:  Science       Date:  1982-01-08       Impact factor: 47.728

9.  Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase.

Authors:  G Sutter; M Ohlmann; V Erfle
Journal:  FEBS Lett       Date:  1995-08-28       Impact factor: 4.124

Review 10.  Bacterial toxins and the nervous system: neurotoxins and multipotential toxins interacting with neuronal cells.

Authors:  Michel R Popoff; Bernard Poulain
Journal:  Toxins (Basel)       Date:  2010-04-15       Impact factor: 4.546

View more
  6 in total

1.  Paediatric Australian bat lyssavirus encephalomyelitis - sequential MRI appearances from symptom onset to death.

Authors:  Umesh Shetty; Mark Phillips; Joshua R Francis; Mark Walsh
Journal:  Pediatr Radiol       Date:  2015-06-17

2.  Potential Exposures to Australian Bat Lyssavirus Notified in Queensland, Australia, 2009-2014.

Authors:  Damin Si; John Marquess; Ellen Donnan; Bruce Harrower; Bradley McCall; Sonya Bennett; Stephen Lambert
Journal:  PLoS Negl Trop Dis       Date:  2016-12-29

Review 3.  Recent observations on Australian bat lyssavirus tropism and viral entry.

Authors:  Dawn L Weir; Edward J Annand; Peter A Reid; Christopher C Broder
Journal:  Viruses       Date:  2014-02-19       Impact factor: 5.048

4.  Host cell virus entry mediated by Australian bat lyssavirus G envelope glycoprotein occurs through a clathrin-mediated endocytic pathway that requires actin and Rab5.

Authors:  Dawn L Weir; Eric D Laing; Ina L Smith; Lin-Fa Wang; Christopher C Broder
Journal:  Virol J       Date:  2014-02-27       Impact factor: 4.099

5.  An eco-epidemiological study of Morbilli-related paramyxovirus infection in Madagascar bats reveals host-switching as the dominant macro-evolutionary mechanism.

Authors:  Julien Mélade; Nicolas Wieseke; Beza Ramasindrazana; Olivier Flores; Erwan Lagadec; Yann Gomard; Steven M Goodman; Koussay Dellagi; Hervé Pascalis
Journal:  Sci Rep       Date:  2016-04-12       Impact factor: 4.379

6.  Isolation and Characterization of Cross-Reactive Human Monoclonal Antibodies That Potently Neutralize Australian Bat Lyssavirus Variants and Other Phylogroup 1 Lyssaviruses.

Authors:  Dawn L Weir; Si'Ana A Coggins; Bang K Vu; Jessica Coertse; Lianying Yan; Ina L Smith; Eric D Laing; Wanda Markotter; Christopher C Broder; Brian C Schaefer
Journal:  Viruses       Date:  2021-03-01       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.